Head to Head Survey: JA Solar (JASO) versus Its Competitors

JA Solar (NASDAQ: JASO) is one of 121 publicly-traded companies in the “Semiconductors & related devices” industry, but how does it contrast to its competitors? We will compare JA Solar to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations.

Earnings & Valuation

This table compares JA Solar and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
JA Solar $2.27 billion $102.89 million 3.68
JA Solar Competitors $2.99 billion $454.69 million 24.26

JA Solar’s competitors have higher revenue and earnings than JA Solar. JA Solar is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

JA Solar has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, JA Solar’s competitors have a beta of 1.08, indicating that their average stock price is 8% more volatile than the S&P 500.

Institutional & Insider Ownership

33.0% of JA Solar shares are owned by institutional investors. Comparatively, 59.2% of shares of all “Semiconductors & related devices” companies are owned by institutional investors. 10.1% of shares of all “Semiconductors & related devices” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for JA Solar and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
JA Solar 1 2 0 0 1.67
JA Solar Competitors 1428 5576 10716 603 2.57

JA Solar presently has a consensus price target of $6.33, indicating a potential downside of 8.35%. As a group, “Semiconductors & related devices” companies have a potential upside of 17.91%. Given JA Solar’s competitors stronger consensus rating and higher possible upside, analysts clearly believe JA Solar has less favorable growth aspects than its competitors.

Profitability

This table compares JA Solar and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
JA Solar 2.84% 7.73% 2.52%
JA Solar Competitors -39.41% 2.68% 2.80%

Summary

JA Solar competitors beat JA Solar on 10 of the 13 factors compared.

About JA Solar

JA Solar Holdings Co., Ltd., together with its subsidiaries, designs, develops, manufactures, and sells solar power products based on crystalline silicon technologies. The company's principal products include monocrystalline and multicrystalline solar cells and modules. It also provides monocrystalline and multicrystalline silicon wafers; solar product processing services; and solar power plant project development and electricity generation services. The company sells its products primarily under the JA Solar brand name, as well as produces original equipment for manufacturers or customers under their brand names. JA Solar Holdings Co., Ltd. sells its solar cell and module products to module manufacturers, system integrators, project developers, and distributors worldwide. The company was founded in 2005 and is based in Beijing, the People's Republic of China.

Receive News & Ratings for JA Solar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JA Solar and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

CNH Industrial  Price Target Raised to $17.00 at UBS
CNH Industrial Price Target Raised to $17.00 at UBS
IOStoken   Trading 19.2% Lower  This Week
IOStoken Trading 19.2% Lower This Week
Primas  Price Tops $0.70
Primas Price Tops $0.70
Oxford Immunotec Global  Rating Increased to Buy at BidaskClub
Oxford Immunotec Global Rating Increased to Buy at BidaskClub
Nabriva Therapeutics  Price Target Raised to $11.00
Nabriva Therapeutics Price Target Raised to $11.00
Intec Pharma  PT Set at $16.00 by HC Wainwright
Intec Pharma PT Set at $16.00 by HC Wainwright


© 2006-2018 Ticker Report. Google+.